Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001045605 | SCV001209468 | pathogenic | MPI-congenital disorder of glycosylation | 2023-06-17 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 843069). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with MPI-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu211Asnfs*7) in the MPI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MPI are known to be pathogenic (PMID: 19862844). |
Baylor Genetics | RCV001045605 | SCV004193724 | pathogenic | MPI-congenital disorder of glycosylation | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001045605 | SCV005633264 | likely pathogenic | MPI-congenital disorder of glycosylation | 2024-03-20 | criteria provided, single submitter | clinical testing |